PRIME PROPERTY | HULTA PHARMA | PRIME PROPERTY/ HULTA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 3.9 | -16.1 | - | View Chart |
P/BV | x | 0.7 | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
PRIME PROPERTY HULTA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PRIME PROPERTY Mar-23 |
HULTA PHARMA Mar-23 |
PRIME PROPERTY/ HULTA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 16 | 10 | 153.3% | |
Low | Rs | 9 | 3 | 305.3% | |
Sales per share (Unadj.) | Rs | 0 | 0 | - | |
Earnings per share (Unadj.) | Rs | 3.6 | -0.4 | -851.7% | |
Cash flow per share (Unadj.) | Rs | 3.9 | -0.4 | -907.3% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 42.0 | -1.2 | -3,497.3% | |
Shares outstanding (eoy) | m | 16.97 | 7.45 | 227.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 0 | - | |
Avg P/E ratio | x | 3.4 | -15.7 | -21.9% | |
P/CF ratio (eoy) | x | 3.2 | -15.7 | -20.6% | |
Price / Book Value ratio | x | 0.3 | -5.6 | -5.3% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 213 | 50 | 426.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 5 | 1 | 487.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 0 | - | |
Other income | Rs m | 37 | 0 | - | |
Total revenues | Rs m | 37 | 0 | - | |
Gross profit | Rs m | -31 | -3 | 1,178.4% | |
Depreciation | Rs m | 4 | 0 | - | |
Interest | Rs m | 2 | 1 | 309.1% | |
Profit before tax | Rs m | 0 | -3 | 9.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -62 | 0 | - | |
Profit after tax | Rs m | 62 | -3 | -1,940.1% | |
Gross profit margin | % | 0 | 0 | - | |
Effective tax rate | % | 21,440.1 | 0 | - | |
Net profit margin | % | 0 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 551 | 0 | 137,702.5% | |
Current liabilities | Rs m | 81 | 0 | 73,845.5% | |
Net working cap to sales | % | 0 | 0 | - | |
Current ratio | x | 6.8 | 3.6 | 186.5% | |
Inventory Days | Days | 0 | 0 | - | |
Debtors Days | Days | 0 | 0 | - | |
Net fixed assets | Rs m | 199 | 0 | 60,387.9% | |
Share capital | Rs m | 85 | 75 | 113.9% | |
"Free" reserves | Rs m | 627 | -83 | -751.6% | |
Net worth | Rs m | 712 | -9 | -7,966.3% | |
Long term debt | Rs m | 0 | 10 | 0.0% | |
Total assets | Rs m | 750 | 1 | 102,753.4% | |
Interest coverage | x | 0.8 | -4.8 | -17.4% | |
Debt to equity ratio | x | 0 | -1.1 | -0.0% | |
Sales to assets ratio | x | 0 | 0 | - | |
Return on assets | % | 8.5 | -361.5 | -2.3% | |
Return on equity | % | 8.7 | 35.6 | 24.4% | |
Return on capital | % | 0.2 | -425.6 | -0.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | -3 | 21.8% | |
From Investments | Rs m | 11 | NA | - | |
From Financial Activity | Rs m | -2 | 3 | -48.8% | |
Net Cashflow | Rs m | 9 | 0 | -30,533.3% |
Indian Promoters | % | 72.6 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 56.3 | - | |
Indian inst/Mut Fund | % | 0.0 | 1.1 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 27.4 | 43.7 | 62.8% | |
Shareholders | 3,366 | 3,820 | 88.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PRIME PROPERTY With: DLF OMAXE PHOENIX MILL PRESTIGE ESTATES PSP PROJECTS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | PRIME PROPERTY | HULTA PHARMA |
---|---|---|
1-Day | -3.13% | 4.91% |
1-Month | 9.46% | -4.00% |
1-Year | 103.41% | 72.81% |
3-Year CAGR | 48.85% | 26.49% |
5-Year CAGR | 5.52% | 1.50% |
* Compound Annual Growth Rate
Here are more details on the PRIME PROPERTY share price and the HULTA PHARMA share price.
Moving on to shareholding structures...
The promoters of PRIME PROPERTY hold a 72.6% stake in the company. In case of HULTA PHARMA the stake stands at 56.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PRIME PROPERTY and the shareholding pattern of HULTA PHARMA.
Finally, a word on dividends...
In the most recent financial year, PRIME PROPERTY paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
HULTA PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of PRIME PROPERTY, and the dividend history of HULTA PHARMA.
For a sector overview, read our finance sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.